LEGN - Balance Sheet - Legend Biotech Corporation

Current Liabilities	278 M
Accounts Payable	37.2 M
Short-Term Debt	4.79 M
Other Current Liabilities	236 M
Non-Current Liabilities	352 M
Long-Term Debt	346 M
Other Non-Current Liabilities	6.15 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	286.7	1 277.7	786.0	688.9	455.7	83.4	210.2	2.1
Short Term Investments	835.9	31.0	239.6	193.5	50.0	75.6	6.0	0
Receivables	124.9	157.1	45.5	50.5	75.6	35.8	108.6	228.0
Inventory	23.9	19.4	10.4	1.7	1.8	1.2	1.1	11 K
Other Current Assets	12.4	12.6	62.8	15.2	10.8	11.3	1.1	0.8
Total Current Assets	1 283.9	1 497.8	1 099.1	948.8	592.9	207.1	327.0	230.9
PP&E	201.6	189.7	161.7	155.1	121.3	75.5	33.1	2.9
Intangible Assets	174.2	4.1	3.4	4.7	7.7	5.1	49 K	2 K
Goodwill	0	0	0	0	(4.9)	0	0	0
Long Term Investments	4.4	4.4	0.4	4.7	0	0	(1.2)	(4.9)
Other Long Term Assets	6.1	152.4	66.8	5.1	4.0	0	1.2	4.9
Other Assets	0	0	0	0	0	0	0	1
Total Assets	1 670.2	1 848.6	1 331.0	1 118.4	721.0	287.7	429.0	238.7
LIABILITIES
Accounts Payable	37.2	20.2	32.9	7.0	4.9	9.6	7.3	4.3
Short Term Debt	4.8	3.2	7.1	0.9	1.5	1.0	0.4	64 K
Other Current Liabilities	164.7	132.9	248.0	220.7	100.1	70.9	36.6	38.4
Total Current Liabilities	277.6	216.4	297.8	280.3	161.2	127.8	159.2	52.1
Long Term Debt	345.8	325.5	281.0	122.1	1.9	5.1	3.9	0.2
Deferred Tax Income	0	0	0	1.9	2.1	(42.0)	(213.2)	(174.2)
Other Liabilities	0	56 K	7.9	2.3	2.6	0	0	0
Total Liabilities	629.6	597.2	586.7	647.2	440.8	410.6	420.4	226.5
EQUITY
Common Stock	37 K	36 K	33 K	31 K	27 K	20 K	20 K	20 K
Retained Earnings	(1 661.7)	(1 484.7)	(966.5)	(817.0)	(430.8)	(127.3)	5.7	8.5
Other Accumulative Comprehensive Income/Loss	(68.2)	98.9	744.3	471.2	280.2	(122.9)	8.6	(0.2)
Total Equity	1 040.5	1 251.4	744.3	471.2	280.3	(122.9)	8.6	12.2
Total Liabilities and Equity	1 670.2	1 848.6	1 331.0	1 118.4	721.0	287.7	429.0	238.7
SHARES OUTSTANDING
Common Shares Outstanding	91.4	88.0	79.5	70.4	59.1	66.0	50.0	66.0

Free